H Keipp B Talbot

Summary

Affiliation: Vanderbilt University
Country: USA

Publications

  1. ncbi Association between obesity and vulnerability and serologic response to influenza vaccination in older adults
    H K Talbot
    Division of Infectious Diseases, Department of Medicine, A2200 MCN, 1161 21st Ave S, Nashville, TN 37232, USA
    Vaccine 30:3937-43. 2012
  2. ncbi Effectiveness of seasonal vaccine in preventing confirmed influenza-associated hospitalizations in community dwelling older adults
    H Keipp Talbot
    Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee 37232, USA
    J Infect Dis 203:500-8. 2011
  3. ncbi Immunopotentiation of trivalent influenza vaccine when given with VAX102, a recombinant influenza M2e vaccine fused to the TLR5 ligand flagellin
    H Keipp Talbot
    Division of Infectious Diseases, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee, United States of America
    PLoS ONE 5:e14442. 2010
  4. ncbi Failure of routine diagnostic methods to detect influenza in hospitalized older adults
    H Keipp Talbot
    Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee 37232, USA
    Infect Control Hosp Epidemiol 31:683-8. 2010
  5. ncbi The diagnosis of viral respiratory disease in older adults
    H Keipp Talbot
    Department of Medicine, Vanderbilt University School of Medicine, Nashville, Tennessee, USA
    Clin Infect Dis 50:747-51. 2010
  6. ncbi The pediatric burden of human coronaviruses evaluated for twenty years
    H Keipp Talbot
    Division of Infectious Diseases, Department of Medicine, Vanderbilt University School of Medicine, Nashville, TN, USA
    Pediatr Infect Dis J 28:682-7. 2009
  7. ncbi Influenza in older adults: impact of vaccination of school children
    H Keipp Talbot
    Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, United States
    Vaccine 27:1923-7. 2009
  8. ncbi Coronavirus infection and hospitalizations for acute respiratory illness in young children
    H Keipp B Talbot
    Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee, USA
    J Med Virol 81:853-6. 2009
  9. ncbi Immunogenicity, safety and consistency of new trivalent inactivated influenza vaccine
    H Keipp Talbot
    Vanderbilt University School of Medicine and Pediatrics, Vanderbilt University Medical Center, 1161 21st Avenue South, Nashville, TN 37232, USA
    Vaccine 26:4057-61. 2008
  10. ncbi Influenza vaccination for older adults
    H Keipp B Talbot
    Departments of Pediatrics, Vanderbilt University Medical Center, Nashville, TN, USA
    Hum Vaccin Immunother 8:96-101. 2012

Detail Information

Publications10

  1. ncbi Association between obesity and vulnerability and serologic response to influenza vaccination in older adults
    H K Talbot
    Division of Infectious Diseases, Department of Medicine, A2200 MCN, 1161 21st Ave S, Nashville, TN 37232, USA
    Vaccine 30:3937-43. 2012
    ..Few other host factors are known to be associated with serologic response. Our objective was to determine whether obesity and vulnerability independently predicted serologic response to influenza vaccination...
  2. ncbi Effectiveness of seasonal vaccine in preventing confirmed influenza-associated hospitalizations in community dwelling older adults
    H Keipp Talbot
    Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee 37232, USA
    J Infect Dis 203:500-8. 2011
    ..Current evidence supporting the effectiveness of influenza vaccine in preventing hospitalizations in older adults is insufficient...
  3. ncbi Immunopotentiation of trivalent influenza vaccine when given with VAX102, a recombinant influenza M2e vaccine fused to the TLR5 ligand flagellin
    H Keipp Talbot
    Division of Infectious Diseases, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee, United States of America
    PLoS ONE 5:e14442. 2010
    ..The objectives of this study were to assess the feasibility of giving VAX102 and TIV in combination in an effort to achieve greater immunogenicity and to provide cross-protection...
  4. ncbi Failure of routine diagnostic methods to detect influenza in hospitalized older adults
    H Keipp Talbot
    Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee 37232, USA
    Infect Control Hosp Epidemiol 31:683-8. 2010
    ..To define the utility of using routine diagnostic methods to detect influenza in older, hospitalized adults...
  5. ncbi The diagnosis of viral respiratory disease in older adults
    H Keipp Talbot
    Department of Medicine, Vanderbilt University School of Medicine, Nashville, Tennessee, USA
    Clin Infect Dis 50:747-51. 2010
    ....
  6. ncbi The pediatric burden of human coronaviruses evaluated for twenty years
    H Keipp Talbot
    Division of Infectious Diseases, Department of Medicine, Vanderbilt University School of Medicine, Nashville, TN, USA
    Pediatr Infect Dis J 28:682-7. 2009
    ..The epidemiology of human coronaviruses (HCoVs) has not been established using reverse transcription polymerase chain reaction techniques in a specimen collection that spans decades...
  7. ncbi Influenza in older adults: impact of vaccination of school children
    H Keipp Talbot
    Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, United States
    Vaccine 27:1923-7. 2009
    ..59, 2.04) in the intervention county and 1.53 (95% CI 0.71, 2.34) in the control county. These rates did not differ significantly except in the subgroup aged 50 -- 64 years where rates in the intervention county were significantly lower...
  8. ncbi Coronavirus infection and hospitalizations for acute respiratory illness in young children
    H Keipp B Talbot
    Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee, USA
    J Med Virol 81:853-6. 2009
    ..2 (95% CI 4.3, 17.6), 4.2 (95% CI 1.9, 6.9), and 0 (95% CI 0, 3.7) in children aged <6 months, 6-23 months, and 24-59 months, respectively. Coronaviruses were identified in a modest number of hospitalized children...
  9. ncbi Immunogenicity, safety and consistency of new trivalent inactivated influenza vaccine
    H Keipp Talbot
    Vanderbilt University School of Medicine and Pediatrics, Vanderbilt University Medical Center, 1161 21st Avenue South, Nashville, TN 37232, USA
    Vaccine 26:4057-61. 2008
    ..9% against H3N2 component, and 94.2% against influenza B. Few local or systemic adverse events were noted after vaccination with either TIV presentation. TIV was well tolerated and immunogenic...
  10. ncbi Influenza vaccination for older adults
    H Keipp B Talbot
    Departments of Pediatrics, Vanderbilt University Medical Center, Nashville, TN, USA
    Hum Vaccin Immunother 8:96-101. 2012
    ..In the meantime, the currently licensed influenza vaccines need to be administered annually to prevent the estimated 90,000 hospitalizations and 5,000 deaths attributed to influenza in adults ≥65 y of age each year...